Treatments known as biologics - which work by switching off the immune system reaction that drives inflammation - are on the ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP), its second indication after severe asthma. The anti-TSLP antibody has ...

After the fasting, the uncomfortable cleanse and a drowsy ride home, it's a relief to have your colonoscopy screening behind ...

Last week's biggest large-cap laggards were Nike, Arm, and Lennar, sliding on weak China demand, analyst downgrades, earnings ...

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use has recommended the granting of a marketing authorization for Exdensur (depemokimab, GlaxoSmithKline) for severe ...

A JAMA study shows eating ultra-processed foods may increase the risk of developing pre-cancerous polyps. Trump changes course, says House Republicans should vote to release Epstein files Yungblud ...

Eating ultra-processed foods could lead to an increased risk of being diagnosed with precancerous colorectal growths for women under 50, according to new research. A study, published Thursday in JAMA ...

Eating more ultra-processed foods is tied to an increased risk of precancerous colorectal growths in women under 50, according to a study published Thursday in JAMA Oncology. These growths, called ...

Tezspire is the first biologic approved for CRSwNP targeting TSLP, expanding its respiratory indications. The drug acts on airway epithelium, inhibiting TSLP, an early-stage inflammatory cytokine. The ...

Getting a cold once or twice a few months is normal, but what about a persistently blocked nose that lingers for weeks and causes ongoing discomfort? It may be tempting to ignore, but persistent nasal ...